Learn more at rsvfacts.com.
Dr. Mitchell Goldstein is Medical Director Emeritus and Fellowship Coordinator of the Neonatal ICU in the Family Birth & Newborn Center. He is on the editorial board of the Journal of Perinatology. He is past president of the Perinatal Advisory Council: Leadership, Advocacy & Consultation, the editor of PAC-LAC's Guidelines of Care, and PAC-LAC's CME Research Chairman. He is on the board of the American Academy of Pediatrics Perinatal Section and an Associate Professor in Pediatrics at Loma Linda University Medical Center. He is Board Certified in both Pediatrics and Neonatal-Perinatal Medicine, and is a Fellow of the American Academy of Pediatrics.
Vanessa
Moore’s daughter, Sydney, was born at 34 weeks gestational age during
the peak of RSV season. Despite being born 6 weeks before term, Sydney’s
doctors deemed her healthy and didn’t discuss the option of preventive
treatment for
RSV. Vanessa took every precaution to keep her daughter safe during the
same RSV season – constantly sanitizing hands and toys, avoiding crowds
and even skipping family gatherings – but Sydney still contracted the
highly contagious virus and was hospitalized
for nearly a week. After
it became clear that Sydney would benefit from added protection, her
doctors prescribed the preventive therapy but she was quickly denied
coverage. Over the course of several months, Vanessa and Sydney’s
doctors pleaded with their
insurance company to obtain coverage, but they were denied time and
time again. Meanwhile, Sydney had three more RSV-related
hospitalizations that year. Vanessa lives with her husband and three
children in Virginia.
No comments:
Post a Comment